[{"address1": "12265 El Camino Real", "address2": "Suite 350", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 727 1040", "fax": "858 614 7007", "website": "https://www.connectbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California.", "fullTimeEmployees": 81, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barry D. Quart Pharm.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David L. Szekeres J.D.", "age": 50, "title": "President", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Peraza CPA", "age": 47, "title": "Vice President of Finance", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Cohn J.D.", "title": "General Counsel & Corporate Secretary", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lei  Sun Ph.D.", "age": 60, "title": "VP of Biologics & Head of CMC", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul  Collazo Ph.D.", "title": "VP & Global Head of Medical Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Srikanth  Pendyala M.D.", "title": "Senior Vice President of Clinical Development(Consultant)", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly J. Manhard", "age": 64, "title": "Chief Development Officer", "yearBorn": 1960, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9, "open": 0.841, "dayLow": 0.841, "dayHigh": 0.9099, "regularMarketPreviousClose": 0.9, "regularMarketOpen": 0.841, "regularMarketDayLow": 0.841, "regularMarketDayHigh": 0.9099, "payoutRatio": 0.0, "beta": -0.489, "forwardPE": -4.5495, "volume": 10310, "regularMarketVolume": 10310, "averageVolume": 25388, "averageVolume10days": 20890, "averageDailyVolume10Day": 20890, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 50275616, "fiftyTwoWeekLow": 0.765, "fiftyTwoWeekHigh": 2.66, "priceToSalesTrailing12Months": 2.084741, "fiftyDayAverage": 1.01672, "twoHundredDayAverage": 1.227535, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -59640356, "profitMargins": -0.88655, "floatShares": 14791504, "sharesOutstanding": 55254000, "sharesShort": 29790, "sharesShortPriorMonth": 40847, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0005, "heldPercentInsiders": 0.4116, "heldPercentInstitutions": 0.44854, "shortRatio": 1.9, "shortPercentOfFloat": 0.001, "impliedSharesOutstanding": 55254000, "bookValue": 1.999, "priceToBook": 0.4551776, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -21380000, "trailingEps": -0.39, "forwardEps": -0.2, "enterpriseToRevenue": -2.473, "enterpriseToEbitda": 2.39, "52WeekChange": -0.3389706, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 0.9099, "targetHighPrice": 8.0, "targetLowPrice": 6.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 110241000, "totalCashPerShare": 1.995, "ebitda": -24951000, "totalDebt": 325000, "quickRatio": 11.825, "currentRatio": 12.043, "totalRevenue": 24116000, "debtToEquity": 0.294, "revenuePerShare": 0.438, "returnOnAssets": -0.12134, "returnOnEquity": -0.17916, "grossProfits": 24116000, "freeCashflow": -17080772, "operatingCashflow": -24749000, "grossMargins": 1.0, "ebitdaMargins": -1.0346199, "operatingMargins": 0.24639, "financialCurrency": "USD", "symbol": "CNTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Connect Biopharma Holdings Limi", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "corporateActions": [], "postMarketTime": 1740781835, "regularMarketTime": 1740776400, "exchange": "NGM", "messageBoardId": "finmb_706016439", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.1000037, "regularMarketPrice": 0.9099, "longName": "Connect Biopharma Holdings Limited", "postMarketChangePercent": -1.08804, "postMarketPrice": 0.9, "postMarketChange": -0.00990003, "regularMarketChange": 0.0099000335, "regularMarketDayRange": "0.841 - 0.9099", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 25388, "fiftyTwoWeekLowChange": 0.14490002, "fiftyTwoWeekLowChangePercent": 0.1894118, "fiftyTwoWeekRange": "0.765 - 2.66", "fiftyTwoWeekHighChange": -1.7501001, "fiftyTwoWeekHighChangePercent": -0.65793234, "fiftyTwoWeekChangePercent": -33.89706, "earningsTimestampStart": 1725566700, "earningsTimestampEnd": 1725566700, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.39, "epsForward": -0.2, "epsCurrentYear": -0.215, "priceEpsCurrentYear": -4.232093, "fiftyDayAverageChange": -0.10682005, "fiftyDayAverageChangePercent": -0.10506338, "twoHundredDayAverageChange": -0.317635, "twoHundredDayAverageChangePercent": -0.2587584, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "cryptoTradeable": false, "displayName": "Connect Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]